Teva Pharmaceutical Industries Limited · TASE:TEVA
Shields Matthew sold 16,195 Teva Pharmaceutical Industries Limited shares (Form 4)
Traded Jun 3, 2026 · Filed Jun 4, 2026
On Jun 3, 2026, Shields Matthew (EVP, Global Operations) sold 16,195 Teva Pharmaceutical Industries Limited shares at US$32.87 for US$532K under a trading plan, leaving 9,989 shares. Filed Jun 4, 2026 (Form 4).
- Sold
- 16,195 shares
- Price
- US$32.87
- Value
- US$532K
- Holding after
- 9,989 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Global Operations
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Ordinary Shares | Option exercise | 16,195 | 26,184 | Direct | |
| Jun 3, 2026 | Ordinary Shares | Sale | 16,195 | US$32.87 | 9,989 | Direct |
Source
Related
- Teva Pharmaceutical Industries Limited
- Shields Matthew
- Teva Pharmaceutical Industries Limited shareholders
- Form 4 · Shields Matthew · Jun 22, 2026
- Form 4 · Savage Brian · Sep 22, 2026
- Form 4 · Mignone Roberto · Sep 22, 2026
- Form 4 · Weiss Amir · Aug 25, 2026
- Form 4 · Satchi-Fainaro Ronit · Aug 25, 2026
- Form 4 · Lippman Evan · Aug 19, 2026